162 related articles for article (PubMed ID: 16149624)
21. [DU-PAN-2, SPan-1].
Motoo Y; Sawabu N
Nihon Rinsho; 2005 Aug; 63 Suppl 8():687-90. PubMed ID: 16149612
[No Abstract] [Full Text] [Related]
22. [Galactosyltransferase isozyme II (GT-II) as a new tumor marker for ovarian cancers--especially for clear cell carcinoma].
Nozawa S; Kiguchi K; Yajima M; Udagawa Y; Sakuma T; Iizuka R; Narisawa S; Sakayori M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1341-7. PubMed ID: 2511259
[TBL] [Abstract][Full Text] [Related]
23. Clinical value of serum glycoprotein galactosyltransferase levels in different histological types of ovarian carcinoma.
Gauduchon P; Tillier C; Guyonnet C; Heron JF; Bar-Guilloux E; Le Talaer JY
Cancer Res; 1983 Sep; 43(9):4491-6. PubMed ID: 6409405
[TBL] [Abstract][Full Text] [Related]
24. [Studies of clinical usefulness of new tumor markers of ovarian cancer, CA 54/61 and CA 602--CA 602 assay reagent kit, performance its normal value and correlations with other tumor markers].
Nozawa S; Udagawa Y; Sasaki H; Ito K; Akiya K; Terashima Y; Takamizawa H; Ohkura H; Fujimoto S; Hashimoto M
Gan To Kagaku Ryoho; 1992 Oct; 19(12):2085-93. PubMed ID: 1417016
[TBL] [Abstract][Full Text] [Related]
25. [Lysophospholipids].
Nakamura K; Yatomi Y
Nihon Rinsho; 2005 Aug; 63 Suppl 8():809-11. PubMed ID: 16149647
[No Abstract] [Full Text] [Related]
26. [Basic fibroblast growth factor (bFGF/FGF-2) in urine].
Ishiwata T; Naito Z
Nihon Rinsho; 2005 Aug; 63 Suppl 8():768-70. PubMed ID: 16149636
[No Abstract] [Full Text] [Related]
27. [2-->6 Sialyl Le(a) antigen].
Miyazaki K; Kannagi R
Nihon Rinsho; 2005 Aug; 63 Suppl 8():663-8. PubMed ID: 16149606
[No Abstract] [Full Text] [Related]
28. [Cadherin family].
Fujiya T; Yamanami H; Kakukawa Y
Nihon Rinsho; 2005 Aug; 63 Suppl 8():151-3. PubMed ID: 16149475
[No Abstract] [Full Text] [Related]
29. [CA15-3].
Inaji H
Nihon Rinsho; 2005 Aug; 63 Suppl 8():651-3. PubMed ID: 16149603
[No Abstract] [Full Text] [Related]
30. [CA19-9].
Odagiri E
Nihon Rinsho; 2005 Aug; 63 Suppl 8():642-4. PubMed ID: 16149600
[No Abstract] [Full Text] [Related]
31. [Prostatic acid phosphatase (PAP)].
Kuriyama M
Nihon Rinsho; 2005 Aug; 63 Suppl 8():702-4. PubMed ID: 16149616
[No Abstract] [Full Text] [Related]
32. [PIVKA-II].
Tsuchiya T
Nihon Rinsho; 2005 Aug; 63 Suppl 8():713-6. PubMed ID: 16149620
[No Abstract] [Full Text] [Related]
33. New screen could 'change the prognosis' for ovarian cancer.
Dis Manag Advis; 2003 Jan; 9(1):1-4. PubMed ID: 12619292
[No Abstract] [Full Text] [Related]
34. [CYFRA21-1].
Kitamura S
Nihon Rinsho; 2005 Aug; 63 Suppl 8():654-8. PubMed ID: 16149604
[No Abstract] [Full Text] [Related]
35. [KMO1].
Kamigaki T; Kuroda Y
Nihon Rinsho; 2005 Aug; 63 Suppl 8():691-3. PubMed ID: 16149613
[No Abstract] [Full Text] [Related]
36. [Histamine release test (HRT)].
Yamatodani A
Nihon Rinsho; 2010 Jun; 68 Suppl 6():36-40. PubMed ID: 20941996
[No Abstract] [Full Text] [Related]
37. [Blood serum galactosyltransferase in oncologic diseases].
Mikhaĭlov AD; Zhordaniia KI; Ivanov PK
Med Radiol (Mosk); 1989 Mar; 34(3):31-4. PubMed ID: 2494414
[TBL] [Abstract][Full Text] [Related]
38. [Hepatitis delta virus (HDV) marker].
Inoue O; Kubota Y; Senoo T
Nihon Rinsho; 2010 Jun; 68 Suppl 6():454-7. PubMed ID: 20942102
[No Abstract] [Full Text] [Related]
39. [Detection of CA 125 in the serum and tissue of patients with ovarian neoplasms].
Kristen P; Beier HJ; Kaesemann H; Caffier H
Gynakol Rundsch; 1989; 29 Suppl 2():358-60. PubMed ID: 2693257
[No Abstract] [Full Text] [Related]
40. [Thrombomodulin].
Yatomi Y
Nihon Rinsho; 2004 Dec; 62 Suppl 12():742-4. PubMed ID: 15658439
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
